Related references
Note: Only part of the references are listed.The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
Mette S. van Ramshorst et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Fertility preservation and cancer: challenges for adolescent and young adult patients
Catherine Benedict et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2016)
Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women
Yubei Huang et al.
SCIENTIFIC REPORTS (2016)
Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study
Kavitha Krishnan et al.
BREAST CANCER RESEARCH (2016)
Gene expression in young adult type breast cancer: a retrospective analysis
Rebecca H. Johnson et al.
ONCOTARGET (2015)
Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study
G. Houvenaeghel et al.
ANNALS OF ONCOLOGY (2014)
Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis
T. Gamucci et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The Relationship of Mammographic Density and Age: Implications for Breast Cancer Screening
Cristina M. Checka et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Clinical Features and Survival Analysis of T1mic, a, bN0M0 Breast Cancer
Junnan Li et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged aparts per thousandcurrency sign40 years
Maurice J. C. van der Sangen et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype
Rachel L. Theriault et al.
CLINICAL BREAST CANCER (2011)
Stumbling Blocks on the Path to Personalized Medicine in Breast Cancer: The Case of PARP Inhibitors for BRCA1/2-Associated Cancers
Judith Balmana et al.
CANCER DISCOVERY (2011)
Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
Ji Hyun Kwon et al.
BMC CANCER (2010)
Management of small HER2-positive breast cancers
Susana Banerjee et al.
LANCET ONCOLOGY (2010)
Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients
Bas Kreike et al.
CLINICAL CANCER RESEARCH (2009)
High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2-Positive, Node-Negative Tumors 1 cm or Smaller
Ana M. Gonzalez-Angulo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Patient and Tumor Characteristics Associated With Increased Mortality in Young Women (≤40 Years) With Breast Cancer
Ankit Bharat et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage Disease
Jennifer L. Gnerlich et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Carey K. Anders et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Do very young korean breast cancer patients have worse outcomes?
Jeong Kyeung Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma
Emer O. Hanrahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Correlative analyses of plasma cytokine/angiogenic factor (C/AF) profile, gender and outcome in a randomized, three-arm, phase II trial of first-line vandetanib (VAN) and/or carboplatin plus paclitaxel (CP) for advanced non-small cell lung cancer (NSCLC)
E. O. Hanrahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Current perspectives on HER2 testing:: A review of national testing guidelines
M Bilous et al.
MODERN PATHOLOGY (2003)
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
RC Bast et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
